Skip to main content
. 2020 May 15;15(7):1119–1136. doi: 10.1016/j.jtho.2020.05.001

Table 4.

Prioritizing Treatment Options for SCLC

Clinical Scenario Treatment Recommendation Initial Delay, wk Workup Comments
Limited Stage
Untreated Concurrent chemotherapy and radiotherapy <2 standard if radiation therapy is not available start with chemotherapy and add XRT as early as possible
On treatment Concurrent chemotherapy and radiotherapy followed by chemotherapy <2 standard continue with CCRT, keep cycles of chemotherapy to 4, use growth factors away from XRT
Completed treatment PCI 2–8 standard
Observation >8 may delay imaging for a mo Flow up by teleclinic
Extensive Stage
Untreated Chemotherapy <2 standard should start on time. Consider growth factors or dose reduction, consider oral etoposide for d 2 and 3
Chemotherapy and immunotherapy <2 standard Be selective
On treatment chemotherapy <2 may extend assessment for 3 cycles if stable
Chemotherapy and immunotherapy <2
Completed treatment Observation 2–8 May extend up to 2 mo if asymptomatic by teleclinic

CCRT, concurrent chemoradiation therapy; PCI, prophylactic cranial irradiation; XRT, radiation therapy.